117 related articles for article (PubMed ID: 10887171)
21. Regulation of neutral sphingomyelinase-2 (nSMase2) by tumor necrosis factor-alpha involves protein kinase C-delta in lung epithelial cells.
Clarke CJ; Guthrie JM; Hannun YA
Mol Pharmacol; 2008 Oct; 74(4):1022-32. PubMed ID: 18653803
[TBL] [Abstract][Full Text] [Related]
22. The involvement of novel protein kinase C isozymes in influencing sensitivity of breast cancer MCF-7 cells to tumor necrosis factor-alpha.
Basu A
Mol Pharmacol; 1998 Jan; 53(1):105-11. PubMed ID: 9443937
[TBL] [Abstract][Full Text] [Related]
23. Urinary trypsin inhibitor, a Kunitz-type protease inhibitor, modulates tumor necrosis factor-stimulated activation and translocation of protein kinase C in U937 cells.
Kobayashi H; Sugino D; Terao T
Int J Oncol; 1998 Jan; 12(1):95-105. PubMed ID: 9454892
[TBL] [Abstract][Full Text] [Related]
24. Activation of protein kinase C by tumor necrosis factor-alpha in human non-pigmented ciliary epithelium.
Prasanna G; Dibas A; Brown K; Yorio T
J Ocul Pharmacol Ther; 1998 Oct; 14(5):401-12. PubMed ID: 9811229
[TBL] [Abstract][Full Text] [Related]
25. Ceramide-induced translocation of protein kinase C-delta and -epsilon to the cytosol. Implications in apoptosis.
Sawai H; Okazaki T; Takeda Y; Tashima M; Sawada H; Okuma M; Kishi S; Umehara H; Domae N
J Biol Chem; 1997 Jan; 272(4):2452-8. PubMed ID: 8999958
[TBL] [Abstract][Full Text] [Related]
26. Tumor necrosis factor-alpha stimulates fractalkine production by mesangial cells and regulates monocyte transmigration: down-regulation by cAMP.
Chen YM; Lin SL; Chen CW; Chiang WC; Tsai TJ; Hsieh BS
Kidney Int; 2003 Feb; 63(2):474-86. PubMed ID: 12631113
[TBL] [Abstract][Full Text] [Related]
27. Effect of tumor necrosis factor-alpha on insulin signal transduction in rat adipocytes: relation to PKCbeta and zeta translocation.
Miura A; Ishizuka T; Kanoh Y; Ishizawa M; Itaya S; Kimura M; Kajita K; Yasuda K
Biochim Biophys Acta; 1999 Apr; 1449(3):227-38. PubMed ID: 10209302
[TBL] [Abstract][Full Text] [Related]
28. CTP:phosphocholine cytidylyltransferase inhibition by ceramide via PKC-alpha, p38 MAPK, cPLA2, and 5-lipoxygenase.
Awasthi S; Vivekananda J; Awasthi V; Smith D; King RJ
Am J Physiol Lung Cell Mol Physiol; 2001 Jul; 281(1):L108-18. PubMed ID: 11404253
[TBL] [Abstract][Full Text] [Related]
29. Differential effects of tumor necrosis factor-alpha on protein kinase C isoforms alpha and delta mediate inhibition of insulin receptor signaling.
Rosenzweig T; Braiman L; Bak A; Alt A; Kuroki T; Sampson SR
Diabetes; 2002 Jun; 51(6):1921-30. PubMed ID: 12031982
[TBL] [Abstract][Full Text] [Related]
30. Tumor necrosis factor-alpha inhibition of 17 alpha-hydroxylase/C17-20 lyase gene (Cyp17) expression.
Li X; Youngblood GL; Payne AH; Hales DB
Endocrinology; 1995 Aug; 136(8):3519-26. PubMed ID: 7628389
[TBL] [Abstract][Full Text] [Related]
31. Rottlerin, a PKC isozyme-selective inhibitor, affects signaling events and cytokine production in human monocytes.
Kontny E; Kurowska M; Szczepańska K; Maśliński W
J Leukoc Biol; 2000 Feb; 67(2):249-58. PubMed ID: 10670587
[TBL] [Abstract][Full Text] [Related]
32. Activation of protein kinase C enhances TNF-alpha-induced differentiation by preventing apoptosis via rapid up-regulation of c-Myc protein expression in HL-60 cells.
Kumakura S; Ishikura H; Maniwa Y; Munemasa S; Tsumura H; Masuda J; Kobayashi S
Leuk Lymphoma; 2003 Mar; 44(3):497-503. PubMed ID: 12688321
[TBL] [Abstract][Full Text] [Related]
33. Fumonisin B1-induced apoptosis is associated with delayed inhibition of protein kinase C, nuclear factor-kappaB and tumor necrosis factor alpha in LLC-PK1 cells.
Gopee NV; He Q; Sharma RP
Chem Biol Interact; 2003 Oct; 146(2):131-45. PubMed ID: 14597127
[TBL] [Abstract][Full Text] [Related]
34. Tumour necrosis factor-alpha mediates tumour promotion via a PKC alpha- and AP-1-dependent pathway.
Arnott CH; Scott KA; Moore RJ; Hewer A; Phillips DH; Parker P; Balkwill FR; Owens DM
Oncogene; 2002 Jul; 21(31):4728-38. PubMed ID: 12101411
[TBL] [Abstract][Full Text] [Related]
35. Synovial fibroblasts and the sphingomyelinase pathway: sphingomyelin turnover and ceramide generation are not signaling mechanisms for the actions of tumor necrosis factor-alpha.
Gerritsen ME; Shen CP; Perry CA
Am J Pathol; 1998 Feb; 152(2):505-12. PubMed ID: 9466577
[TBL] [Abstract][Full Text] [Related]
36. Growth arrest of the breast cancer cell line, T47D, by TNF alpha; cell cycle specificity and signal transduction.
Pusztai L; Lewis CE; McGee JO
Br J Cancer; 1993 Feb; 67(2):290-6. PubMed ID: 8381656
[TBL] [Abstract][Full Text] [Related]
37. Selective ceramide binding to protein kinase C-alpha and -delta isoenzymes in renal mesangial cells.
Huwiler A; Fabbro D; Pfeilschifter J
Biochemistry; 1998 Oct; 37(41):14556-62. PubMed ID: 9772184
[TBL] [Abstract][Full Text] [Related]
38. Tumor necrosis factor alpha-induced activation of downstream NF-kappaB site of the promoter mediates epithelial ICAM-1 expression and monocyte adhesion. Involvement of PKCalpha, tyrosine kinase, and IKK2, but not MAPKs, pathway.
Chen C; Chou C; Sun Y; Huang W
Cell Signal; 2001 Aug; 13(8):543-53. PubMed ID: 11483407
[TBL] [Abstract][Full Text] [Related]
39. ET-18-OCH3 inhibits nuclear factor-kappa B activation by 12-O-tetradecanoylphorbol-13-acetate but not by tumor necrosis factor-alpha or interleukin 1 alpha.
Daniel LW; Civoli F; Rogers MA; Smitherman PK; Raju PA; Roederer M
Cancer Res; 1995 Nov; 55(21):4844-9. PubMed ID: 7585518
[TBL] [Abstract][Full Text] [Related]
40. Inhibitory effect of epidermal growth factor on resveratrol-induced apoptosis in prostate cancer cells is mediated by protein kinase C-alpha.
Shih A; Zhang S; Cao HJ; Boswell S; Wu YH; Tang HY; Lennartz MR; Davis FB; Davis PJ; Lin HY
Mol Cancer Ther; 2004 Nov; 3(11):1355-64. PubMed ID: 15542774
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
